British scientists have unraveled the mystery of a key immune-system process involved in asthma and allergies – a discovery they said could lead to new treatments for the conditions.
The new finding, led by researchers from Trinity College Dublin and the United Kingdom, provides a better understanding of how white blood cells known as nuocytes generate the body’s immune responses that can lead to asthma or other allergic conditions.
By targeting this process, researchers said, new therapies could be developed to treat asthma and allergies.
The number of people with allergic disease, such as asthma and atopic dermatitis, is increasing globally, according to the study published in the journal Nature Immunology.
Drugs and therapies have traditionally focused on treating the symptoms, avoiding substances that provoke reactions to keep them in check. But new lines of research are aimed at increasing understanding of the processes and cells involved that cause allergic inflammation.